ConductScience.org, home

Paper33658587

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.

Chen E and 18 others. Sci Rep, 2021. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer. Papers, record 33658587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33658587

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
PubMed
Journal
Sci Rep
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
4.03
iCite
Revised in PubMed
2026-04-05
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen EEmmalyn
2Cario CLClinton L
3Leong LLancelote
4Lopez KKaren
5Márquez CPCésar P
6Chu CCarissa
7Li PSPatricia S
8Oropeza EErica
9Tenggara IImelda
10Cowan JJanet
11Simko JPJeffry P
12Chan JMJune M
13Friedlander TTerence
14Wyatt AWAlexander W
15Aggarwal RRahul
16Paris PLPamela L
17Carroll PRPeter R
18Feng FFelix
19Witte JSJohn S

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Cell-Free Nucleic AcidsMajor topic
KallikreinsMajor topic
Prostate-Specific AntigenMajor topic
ProstatectomyMajor topic
Prostatic NeoplasmsMajor topic
Prostatic Neoplasms, Castration-ResistantMajor topic
Adult
Aged
Aged, 80 and over
Area Under Curve
Case-Control Studies
Humans
Logistic Models
Male
Middle Aged
Prostate
ROC Curve

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA088164NCI NIH HHSUnited StatesR01CA088164PubMedNIH RePORTER
R01 CA088164NIH HHSUnited StatesR01CA088164PubMedNIH RePORTER
R01 CA201358NCI NIH HHSUnited StatesR01CA201358PubMed and NIHNIH RePORTER

Download CSV of grants

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130792266Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA.Clin Chem2019https://conductscience.org/library/papers/30792266PubMed
224853859Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.Anal Bioanal Chem2014https://conductscience.org/library/papers/24853859PubMed
326493785Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.Eur Respir J2015https://conductscience.org/library/papers/26493785PubMed
415036649Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer.Cancer Lett2004https://conductscience.org/library/papers/15036649PubMed
530400802Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.J Transl Med2018https://conductscience.org/library/papers/30400802PubMed
612766024Changes in concentration of DNA in serum and plasma during storage of blood samples.Clin Chem2003https://conductscience.org/library/papers/12766024PubMed
711239235Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma.Transfusion2001https://conductscience.org/library/papers/11239235PubMed
932122922Harmonizing Cell-Free DNA Collection and Processing Practices through Evidence-Based Guidance.Clin Cancer Res2020https://conductscience.org/library/papers/32122922PubMed
1023779229Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen.Int Urol Nephrol2013https://conductscience.org/library/papers/23779229PubMed
1111694251About the possible origin and mechanism of circulating DNA apoptosis and active DNA release.Clin Chim Acta2001https://conductscience.org/library/papers/11694251PubMed
1218337732Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.Nat Rev Cancer2008https://conductscience.org/library/papers/18337732PubMed
134959277Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.J Clin Invest1966https://conductscience.org/library/papers/4959277PubMed
1430181813Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis.Oncotarget2018https://conductscience.org/library/papers/30181813PubMed
1519762255The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer.Urol Oncol2011https://conductscience.org/library/papers/19762255PubMed
164629907The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases.J Clin Invest1973https://conductscience.org/library/papers/4629907PubMed
1711861434Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation.Clin Chem2002https://conductscience.org/library/papers/11861434PubMed
1825646427Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/25646427PubMed
1924998118Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.Eur Urol2015https://conductscience.org/library/papers/24998118PubMed
2017875764Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.Clin Cancer Res2007https://conductscience.org/library/papers/17875764PubMed
2127428049Fragment Length of Circulating Tumor DNA.PLoS Genet2016https://conductscience.org/library/papers/27428049PubMed

See all 31 referencesDownload CSV of references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42769660Relevance of existing blood-based biomarkers for detection of hepatocellular carcinoma: a prospective case-control study.J Circ Biomark2026https://conductscience.org/library/papers/42769660PubMed
42396659Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review).Mol Med Rep2026https://conductscience.org/library/papers/42396659PubMed
42122162Liquid Biopsy in Advanced Prostate Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42122162PubMed
42072359Integrative Whole-Genome and Epigenome Profiling of cfDNA in Familial Prostate Cancer: Insights from a Pilot Study.Biomedicines2026https://conductscience.org/library/papers/42072359PubMed
41897554Systematic Review of Methods for Measuring Circulating Cell-Free DNA in Plasma of Healthy Individuals.Diagnostics (Basel)2026https://conductscience.org/library/papers/41897554PubMed
41211651Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer.Prostate2026https://conductscience.org/library/papers/41211651PubMed
40863429The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology.J Pers Med2025https://conductscience.org/library/papers/40863429PubMed
40805284Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management.Cancers (Basel)2025https://conductscience.org/library/papers/40805284PubMed
40565311Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40565311PubMed
39984815Application of Z-scan technique in detecting circulating free DNA for prostate cancer diagnosis and monitoring.Lasers Med Sci2025https://conductscience.org/library/papers/39984815PubMed
39901737Stoichiometric constraints for detection of EV-borne biomarkers in blood.J Extracell Vesicles2025https://conductscience.org/library/papers/39901737PubMed
39872607Early detection of canine hemangiosarcoma via cfDNA fragmentation and copy number alterations in liquid biopsies using machine learning.Front Vet Sci2024https://conductscience.org/library/papers/39872607PubMed
39805703Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling.Genome Res2025https://conductscience.org/library/papers/39805703PubMed
39697489Expanded knowledge of cell-free DNA biology: potential to broaden the clinical utility.Extracell Vesicles Circ Nucl Acids2022https://conductscience.org/library/papers/39697489PubMed
39694939cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer.EJNMMI Res2024https://conductscience.org/library/papers/39694939PubMed
39518429Ultrashort Cell-Free DNA Fragments and Vimentin-Positive Circulating Tumor Cells for Predicting Early Recurrence in Patients with Biliary Tract Cancer.Diagnostics (Basel)2024https://conductscience.org/library/papers/39518429PubMed
39451616Role of Liquid Biopsy in Progressive PSA Patients after Radical Prostatectomy.Diagnostics (Basel)2024https://conductscience.org/library/papers/39451616PubMed
39208374A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease.JCO Precis Oncol2024https://conductscience.org/library/papers/39208374PubMed
39000483Detection and Characterization of Methylated Circulating Tumor DNA in Gastric Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39000483PubMed
38938580Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer.J Extracell Biol2022https://conductscience.org/library/papers/38938580PubMed

See all 51 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
GPI2821PubTator's text mininghttps://conductscience.org/library/genes/2821NCBI Gene
GSTP12950PubTator's text mininghttps://conductscience.org/library/genes/2950NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
NPEPPS9520PubTator's text mininghttps://conductscience.org/library/genes/9520NCBI Gene
PCA350652PubTator's text mininghttps://conductscience.org/library/genes/50652NCBI Gene
RASSF111186PubTator's text mininghttps://conductscience.org/library/genes/11186NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33658587

GET https://conductscience.org/api/papers/v1/33658587/references?page=2